Sustained Hemodynamic Efficacy of Therapy Tailored to Reduce Filling Pressures in Survivors With Advanced Heart Failure
- 19 August 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 96 (4) , 1165-1172
- https://doi.org/10.1161/01.cir.96.4.1165
Abstract
Background During therapy to relieve congestion in advanced heart failure, cardiac filling pressures can frequently be reduced to near-normal levels with improved cardiac output. It is not known whether the early hemodynamic improvement and drug response can be maintained long term. Methods and Results After referral for cardiac transplantation with initially severe hemodynamic decompensation, 25 patients survived without transplantation to undergo hemodynamic reassessment after 8±6 months of treatment tailored to early hemodynamic response. Initial changes included net diuresis, increased ACE inhibitor doses, and frequent addition of nitrates. After 8 months of therapy, early reductions were sustained for pulmonary wedge pressure (24±9 to 15±5 mm Hg early; 12±6 mm Hg late) and systemic vascular resistance (1651±369 to 1207±281 dynes·s −1 ·cm −5 early; 1003±193 dynes·s −1 ·cm −5 late). Acute response to doses persisted at reevaluation. Sustained reduction in filling pressures was accompanied by a progressive increase in stroke volume (42±10 to 56±13 mL early; 79±20 mL late), improved functional class, and freedom from resting symptoms. Study design did not control for amiodarone, which was initiated for arrhythmias in 12 patients and associated with greater improvement in cardiac index (1.8 to 3.2 L·min −1 ·m −2 late on amiodarone versus 2.0 to 2.6 L·min −1 ·m −2 , P <.05). Conclusions During chronic therapy tailored to early hemodynamic response in advanced heart failure, acute vasodilator response persists, and near-normal filling pressures can be maintained in patients who survive without transplantation. Stroke volumes at low filling pressures increase further over time. Chronic hemodynamic improvement was accompanied by symptomatic improvement, but the contributions of the monitored hemodynamic approach, increased vasodilator doses, and comprehensive outpatient management have not yet been established.Keywords
This publication has 27 references indexed in Scilit:
- Clinical and hemodynamic predictors of survival in patients aged <65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathyThe American Journal of Cardiology, 1993
- Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captoprilThe American Journal of Cardiology, 1992
- Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathyThe American Journal of Cardiology, 1991
- Predictive value of inducible atrioventricular nodal reentry after surgery for Wolff-Parkinson-White syndromeJournal of the American College of Cardiology, 1990
- Cardiomyopathy of OverloadNew England Journal of Medicine, 1990
- Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1987
- Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to Coronary artery disease or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1986
- Hemodynamic effects of vasodilators and long-term response in heart failureJournal of the American College of Cardiology, 1984
- Matching of myocardial oxygen consumption to mechanical load in human left ventricular hypertrophy and dysfunctionJournal of the American College of Cardiology, 1984
- Effects of increasing left ventricular filling pressure in patients with acute myocardial infarctionJournal of Clinical Investigation, 1970